Institut De Recherches Internationales Servier

This study tests a new combination of drugs (ivosidenib, durvalumab, and chemotherapy) as a first treatment for people with advanced bile duct cancer that has a specific IDH1 gene mutation. The goal is to see if the combination is safe and shrinks tumors. About 52 adults with ino…